Core Insights - Inflation poses significant challenges for investors, impacting corporate costs and consumer spending, which in turn affects financial results [1] - Investing in equities can serve as a hedge against inflation, with certain companies performing well even during inflationary periods [2] Vertex Pharmaceuticals - Vertex Pharmaceuticals is a leading biotech firm that benefits from strong pricing power due to patent protections, allowing it to charge higher prices for its medications [4] - The company's core cystic fibrosis (CF) franchise has no direct competition, leading to steady revenue and earnings growth over the past decade [5] - Vertex has significant growth potential as CF patients require lifelong treatment, and many eligible patients have yet to start therapy [6] - The company is also developing new therapies, including treatments for rare blood diseases and potential therapies for type 1 diabetes and kidney disease [7] - Vertex's monopoly in the CF market provides it with substantial pricing power, making it resilient to inflation [8] Mastercard - Mastercard's business model is well-suited to navigate inflationary environments, and it offers a strong dividend program [8]
2 Inflation-Proof Growth Stocks That Could Outperform the Market
Yahoo Finance·2025-11-20 14:53